Zeynep Banu Güngör

Prof. Zeynep Banu Güngör

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2014 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
ÖEÖzlem Balcı Ekmekçi
Özlem Balcı Ekmekçi
HEHakan Ekmekçi
Hakan Ekmekçi
ZGZeynep Banu Güngör
Zeynep Banu Güngör
ATAbdullah Tüten
Abdullah Tüten
MTM. Sait Toprak
M. Sait Toprak
HSHüseyin Sönmez
Hüseyin Sönmez

1 September 2011 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
EAErdembileg Anuurad
Erdembileg Anuurad
BEByambaa Enkhmaa
Byambaa Enkhmaa
ZGZeynep Banu Güngör
Zeynep Banu Güngör
WZWei Zhang
Wei Zhang
RTRussell P. Tracy
Russell P. Tracy
LBLars Berglund
Lars Berglund
Objective—: Levels of acute phase reactants are affected by age. The extent to which cardiovascular risk associated with aging is due to an increase in the inflammatory burden is not known. We assessed the relationship with age of inflammatory markers, representing (1) systemic (C-reactive protein, fibrinogen, and serum amyloid-A) and (2) vascular (lipoprotein-associated phospholipase A 2 and pentraxin-3) inflammation. Methods and Results—: We determined lipoprotein-associated phospholipase A 2 mass and activity, C-reactive protein, fibrinogen, serum amyloid-A, and pentraxin-3 levels and other cardiovascular disease risk factors in 336 whites and 224 African Americans. Levels of systemic inflammatory markers increased significantly with age in both ethnic groups ( P <0.05 for all), whereas trend patterns of vascular inflammatory markers did not change significantly with age for either group. In multivariate regression models adjusting for confounding variables, age remained independently associated with a composite Z score for systemic but not vascular inflammation (β=0.250, P <0.001, and β=0.276, P <0.001, for whites and African Americans, respectively). Conclusion—: We report an increase in the systemic but not vascular inflammatory burden with age. Levels of both categories of inflammatory markers with age were similar across ethnicity after adjustment for confounders. Our results underscore the importance of age in evaluating inflammatory markers to assess cardiovascular risk.

1 February 1999 in Cancer Letters
Verified
Journal Article
Closed access
HSH. Sönmez
H. Sönmez
SSS. Süer
S. Süer
ZGZeynep Banu Güngör
Zeynep Banu Güngör
HBH. Baloǧlu
H. Baloǧlu
EKE. Kökoǧlu
E. Kökoǧlu

1 July 2012 in Atherosclerosis
Verified
Journal Article
Closed access
ZGZeynep Banu Güngör
Zeynep Banu Güngör
EAErdembileg Anuurad
Erdembileg Anuurad
BEByambaa Enkhmaa
Byambaa Enkhmaa
WZWei Zhang
Wei Zhang
KKKyoungmi Kim
Kyoungmi Kim
LBLars Berglund
Lars Berglund

1 January 2017 in Journal of Medical Biochemistry
Verified
Journal Article
Open access
PDF file
ZGZeynep Banu Güngör
Zeynep Banu Güngör
NSNurver Sipahioglu
Nurver Sipahioglu
HSHuseyin Sonmez
Huseyin Sonmez
HEHakan Ekmekci
Hakan Ekmekci
STSait Toprak
Sait Toprak
BIBarıs Ilerigelen
Barıs Ilerigelen
Summary: Background: Cardiovascular diseases (CVD) account for approximately 50% of the total deaths in Turkey. Most of them are related with atherosclerotic coronary heart disease. Predictive value of endothelial dysfunction markers related with the earliest stage of atherosclerosis has been getting more attention. We hypothesized that differences in endothelial dysfunction biochemical markers among genders would aid to capture proatherogenic activity that was not diagnosed by conventional risk assessment scoring systems. Methods: We assessed the endothelial dysfuntion markers in 92 Turkish adults who were in the »low CV risk group« according to ESC (European Society of Cardiology)-Score Risk Charts. We compared the males and females. Results: We observed higher endothelial dysfunction rates in males, with higher median and mean levels of e-NOS, ox-LDL before and after adjustment for HDL lowness and obesity (P=0.018, P=0.036 for NOS; P=0.000, P=0.004 for ox-LDL, respectively). Men had higher hs-CRP levels than females before adjustment (P=0.021). Decreased e-NOS levels were related with FMD for females before adjustment for confounders (P=0.028). We also found significant correlation between e-NOS and ox-LDL levels both before (r=0.360, P<0.001) and after adjustment (r=0.366, P<0.01) for confounders which pointed out the nitrosative stress. In multivariate regression analyses, after adjusting for other endothelial dysfunction markers which were not included in the ESC-risk scoring system, decreased e-NOS levels were independently asssociated with impaired flow mediated dilatation for females (odds ratio 0.3; P=0.038). Conclusions: Our results underline the importance of gender in evaluating endothelial dysfunction biochemical markers to assess cardiovascular risk for low CV risk indivuals.

13 July 2017 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
ZGZeynep Banu Güngör
Zeynep Banu Güngör
HEHakan Ekmekçi
Hakan Ekmekçi
ATAbdullah Tüten
Abdullah Tüten
STSait Toprak
Sait Toprak
GAGülsel Ayaz
Gülsel Ayaz
ÖEÖzlem Balcı Ekmekçi
Özlem Balcı Ekmekçi